Skip to content
PharmAthene logo — Offering advanced solutions to safeguard public health from...

PharmAthene

Offering advanced solutions to safeguard public health from biological and chemical threats.

Founded 2001 Post-IPO Secondary Total: $84.30M Biotechnology, Health Care

General Information

Company Name PharmAthene
Founded Year 2001
Industries Biotechnology, Health Care
Funding Stage Post-IPO Secondary
Social

BounceWatch is an independent company data service, not affiliated with PharmAthene. To contact PharmAthene, visit pharmathene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PharmAthene compare?

A PDF of PharmAthene and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PharmAthene soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PharmAthene

PharmAthene is a biodefense-focused company founded in 2001 and based in Annapolis, Maryland. The company is dedicated to developing advanced medical countermeasures to protect public health from biological and chemical threats. Its notable projects include Valortim, a monoclonal antibody for both prophylactic and therapeutic use against anthrax, and Protexia, a recombinant form of human butyrylcholinesterase designed to treat organophosphate intoxication caused by nerve agents. The company's last investment of $19.30M was a Post-IPO Secondary investment at 27 July 2009 led by MPM Capital, HealthCare Ventures, Ontario Teachers' Pension Plan, and Baker Brothers Advisors LLC. Operating within the Biotechnology and Health Care industries, PharmAthene aims to provide innovative solutions to safeguard public health against the ever-evolving landscape of biological and chemical threats.

Business keywords: Biodefense, Medical Countermeasures, Anthrax, Chemical Weapons, Biological Threats, Medical Research, Monoclonal Antibodies, Nerve Agents, Public Health, Pharmaceuticals, Biosecurity, Healthcare Innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Secondary $19.30M 4
MPM Capital, HealthCare Ventures +2
27 Jul 2009
Post IPO Equity Undisclosed 3
Canadian Medical Discoveries Fund, Ontario Teachers' Pension Plan +1
01 Jan 2006
Series B $50.00M 3
MPM Capital, HealthCare Ventures +1
12 Oct 2004
Series A $15.00M -
04 Jan 2003

PharmAthene Alternatives & Competitors

View All Alternatives
PharmAthene vs

Protecting against emerging global health threats.

IPO
1372 employees
Biotechnology, Health Care
PharmAthene vs

Pioneering therapeutic advancements in cancer and inflammatory diseases by targeting unique collagen...

Convertible Note
Biotechnology, Health Care
PharmAthene vs

ImmunAbs Inc. is Specialized Antibody Pharmaceutical Development Biotech Venture. "Hope for Patient...

Series B
11 employees
Biotechnology, Health Care

FAQ About PharmAthene

Offering advanced solutions to safeguard public health from biological and chemical threats.
PharmAthene was founded in 2001.
PharmAthene operates in Biotechnology and Health Care. Its work centres on Biodefense, Medical Countermeasures, Anthrax and Chemical Weapons.
PharmAthene has completed 4 funding rounds, raising a total of $84.30M. The latest funding stage is Post-IPO Secondary.
Top alternatives and competitors to PharmAthene include Emergent BioSolutions, CryptoMedix, ImmunAbs Inc., Halo Therapeutics, BioWa, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PharmAthene and Emergent BioSolutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PharmAthene, https://bouncewatch.com/company/pharmathene, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout